Showing results (231-240 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|May 6, 2024
Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studiesAbdulwahab Teflischi Gharavi, Saeed Irian, Azadeh Niknejad, et al.
Molecular Therapy. Oncology|May 6, 2024
Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cellsTakuma Suzuki, Hiroaki Uchida
Molecular Therapy. Oncology|May 6, 2024
Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulationCatrin Heim, Leonie Hartig, Nadine Weinelt, et al.
Molecular Therapy. Oncology|April 10, 2024
Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancersAleksandra Sikora, Kevin M Sullivan, Sean Dineen, et al.
Molecular Therapy. Oncology|April 10, 2024
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumorsFulvia Troise, Guido Leoni, Emanuele Sasso, et al.
Molecular Therapy. Oncology|April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancersEmil Lou, Joanne Xiu, Yasmine Baca, et al.
Molecular Therapy. Oncology|April 10, 2024
Minute virus of mice shows oncolytic activity against pancreatic cancer cells exhibiting a mesenchymal phenotypeMargaux Vienne, Charlène Lopez, Hubert Lulka, et al.
Molecular Therapy. Oncology|April 10, 2024
CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancerJulian Boutin, Coralie Genevois, Franck Couillaud, et al.
Molecular Therapy. Oncology|April 11, 2024
CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatmentKarin Teppert, Isabella Elias Yonezawa Ogusuku, Caroline Brandes, et al.
Molecular Therapy. Oncology|April 10, 2024
Development of a novel, high-efficacy oncolytic herpes simplex virus type 1 platform equipped with two distinct retargeting modalitiesHyun-Yoo Joo, Hyunjung Baek, Chun-Seob Ahn, et al.
Pageof 41